A share price of West Pharmaceutical Services, Inc [WST] is currently trading at $212.50, down -0.08%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The WST shares have gain 11.61% over the last week, with a monthly amount drifted -8.19%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
West Pharmaceutical Services, Inc [NYSE: WST] stock has seen the most recent analyst activity on March 18, 2025, when Evercore ISI initiated its Outperform rating and assigned the stock a price target of $275. Previously, Deutsche Bank upgraded its rating to Buy on February 14, 2025, and kept the price target unchanged to $250. On January 08, 2025, Citigroup initiated with a Buy rating and assigned a price target of $400 on the stock. Wolfe Research started tracking the stock assigning a Peer Perform rating. UBS upgraded its rating to a Buy and raised its price target to $390 on December 12, 2024. Jefferies upgraded its rating to Buy for this stock on February 07, 2024, and upped its price target to $536. In a note dated June 16, 2023, BofA Securities upgraded an Buy rating on this stock and boosted its target price from $390 to $405.
West Pharmaceutical Services, Inc experienced fluctuations in its stock price throughout the past year between $187.43 and $394.42. Currently, Wall Street analysts expect the stock to reach $393 within the next 12 months. West Pharmaceutical Services, Inc [NYSE: WST] shares were valued at $212.50 at the most recent close of the market. An investor can expect a potential return of 84.94% based on the average WST price forecast.
Analyzing the WST fundamentals
Trailing Twelve Months sales for West Pharmaceutical Services, Inc [NYSE:WST] were 2.89B which represents 2.24% growth. Gross Profit Margin for this corporation currently stands at 0.35% with Operating Profit Margin at 0.2%, Pretax Profit Margin comes in at 0.2%, and Net Profit Margin reading is 0.17%. To continue investigating profitability, this company’s Return on Assets is posted at 0.14, Equity is 0.18 and Total Capital is 0.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.11.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 210.34 points at the first support level, and at 208.19 for the second support level. However, for the 1st resistance point, the stock is sitting at 214.13, and for the 2nd resistance point, it is at 215.77.
Ratios To Look Out For
To put it in perspective, the Current Ratio for West Pharmaceutical Services, Inc [NYSE:WST] is 2.79. As well, the Quick Ratio is 2.11, while the Cash Ratio is 0.88. Considering the valuation of this stock, the price to sales ratio is 5.31, the price to book ratio is 5.73 and price to earnings (TTM) ratio is 31.76.
Transactions by insiders
Recent insider trading involved Witherspoon Charles, VP & Treasurer, that happened on Oct 29 ’24 when 703.0 shares were sold. VP & Treasurer, Witherspoon Charles completed a deal on Aug 19 ’24 to sell 1029.0 shares. Meanwhile, Director Hofmann Thomas W sold 617.0 shares on May 10 ’24.
